Drugs / Femarelle
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01269320 | Jan 2012 → ? | metabolic dysfunction-associated steatohepatitis | Hadassah Medical Organization | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Femarelle | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01269320 ↗ |
| Route | Oral | “two 530mg oral tablets” NCT01269320 ↗ |